Articles

701 Hoosiers choose Obamacare plans at rollout

The administration says fewer than 27,000 people managed to enroll for health insurance last month in the 36 states relying on the problem-filled federal website for President Barack Obama’s overhaul.

Read More

Testosterone drugs raise heart risk, study finds

Testosterone replacement drugs, a $1.6 billion market for Eli Lilly and Co. and others, boosted the odds of having a heart attack, stroke or dying by 29 percent in one of the first studies weighing the therapy's cardiovascular risks.

Read More

Lawmakers considering more changes to patent laws

U.S. lawmakers, influenced by companies including Indianapolis-based Eli Lilly and Co., Cisco Systems Inc. and Qualcomm Inc., are considering the second set of patent-law changes in three years as the courts try to race ahead of Congress.

Read More

Bribery scandals sap Lilly’s China growth

Eli Lilly and Co. has been counting on torrid growth in China to help offset losses from patent expirations in other markets, but now slower growth in the Chinese economy and bribery allegations against Lilly and two other drugmakers have hampered Lilly’s growth there.

Read More

Health law fuels modest rise in costs

It’s long been known that Obamacare would make health benefits more expensive for most employers. Now, it’s finally becoming clearer by how much: about 9 percent, on average, according to a series of actuarial studies.

Read More